Paraneoplastic polycythaemia (ectopic EPO)
Ectopic erythropoietin secretion by a tumour
Overview
Secondary polycythaemia from inappropriate (ectopic) erythropoietin production by a tumour — classically renal cell carcinoma, hepatocellular carcinoma, cerebellar haemangioblastoma (and uterine fibroids). Raised haemoglobin/haematocrit with a HIGH EPO and a normal JAK2 (distinguishing it from polycythaemia vera). Treated by removing the tumour.
Recognise
- Raised haemoglobin/haematocrit (polycythaemia) — hyperviscosity symptoms (headache, plethora, thrombosis)
- Features of the underlying tumour (haematuria/flank mass — renal cell; liver disease — HCC; cerebellar signs — haemangioblastoma)
- HIGH erythropoietin (inappropriate) with NEGATIVE JAK2
Red flags
- Thrombosis from hyperviscosity
- Occult renal/hepatic/cerebellar tumour → investigate
Differentials & how to tell them apart
Investigations
FBC (raised Hb/Hct), serum EPO (HIGH — vs low in polycythaemia vera), JAK2 (negative); imaging to find the tumour (renal/liver/CNS).
Management
Treat the underlying tumour (± venesection for hyperviscosity)
- 1Confirm true polycythaemia with a HIGH EPO and negative JAK2; image to find the tumour (renal/liver/CNS). Treat the tumour (often curative).Gate: HIGH EPO with negative JAK2 points to a secondary/ectopic cause (find the tumour) rather than polycythaemia vera (JAK2-positive, low EPO)
- 2Resect the tumour (resolves the polycythaemia); venesection for symptomatic hyperviscosity meanwhile.
Key points
Raised Hb + HIGH EPO + JAK2-negative = secondary/ectopic polycythaemia — hunt the tumour (renal cell, HCC, cerebellar haemangioblastoma). Polycythaemia vera is the opposite (low EPO, JAK2-positive).
Monitor & prognosis
Hb/Hct; tumour treatment.
Resolves with tumour treatment.
Source: BSH; StatPearls